Back

OS Therapies announces WHO approval of Herlystic brand name for OST-HER2

Verifying
  • OS Therapies announced Herlystic as the approved brand name for OST-HER2.
  • The therapy is also identified by the name daznelimgene lisbac.
  • The World Health Organization approved the Herlystic brand name, according to OS Therapies.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.